Salvia miltiorrhiza in angina pectoris and myocardial infarction: A bibliometric analysis

IF 1.9 4区医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE

European Journal of Integrative Medicine Pub Date : 2025-04-01 DOI:10.1016/j.eujim.2025.102445

Qi Lan , Jin-Wen Wu , Ding-Shan Zhang , Yu-Mei Qian , Xin-Rui Yang , Ting Peng , Zhen-Xun Wan , Ping Liu , Yan Jiang , Meng-Nan Liu

{"title":"Salvia miltiorrhiza in angina pectoris and myocardial infarction: A bibliometric analysis","authors":"Qi Lan , Jin-Wen Wu , Ding-Shan Zhang , Yu-Mei Qian , Xin-Rui Yang , Ting Peng , Zhen-Xun Wan , Ping Liu , Yan Jiang , Meng-Nan Liu","doi":"10.1016/j.eujim.2025.102445","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Angina pectoris and myocardial infarction, as the common causes and symptoms of cardiovascular disease, are one of the important research fields of traditional and complementary medicine. Using bibliometric methods, this study conducted a multidimensional analysis of the research trajectory of Salvia miltiorrhiza in the treatment of angina pectoris and myocardial infarction from 2007 to 2024, with a focus on its research characteristics, hot spots and frontiers.</div></div><div><h3>Methods</h3><div>Title, topic, abstract and author keywords related to Salvia miltiorrhiza, myocardial infarction and angina pectoris were utilized in the Web of Science Core Collection database to maximize the search related to the research topic. Co-authorship, co-occurrence and co-citation analysis of publications, countries, institutions, journals, authors, references and keywords were conducted using Citespace 6.3.R1, SCImago Graphica Beta 1.0.42, VOSviewer, Bibliometrix R Package and Microsoft Excel.</div></div><div><h3>Results</h3><div>The annual publication volume of studies related to the treatment of angina pectoris and myocardial infarction using Salvia miltiorrhiza exhibits phased changes, demonstrating a general upward trend. China is the country with the highest number of publications and citations, and it has established collaborations with multiple countries. Canada and India have emerged as significant participants in recent years. The number of authors and publications meets the requirements of Price's Law and the core author in this research field is Li, Xiang. The top three keywords are Salvia miltiorrhiza (75 occurrences), myocardial infarction (70 occurrences) and Danshen(37 occurrences).</div></div><div><h3>Conclusions</h3><div>The current hotspots of Salvia miltiorrhiza in the treatment of angina pectoris and myocardial infarction mainly focus on three aspects: the pharmacological effects of this herb and its active ingredients, the treatment mechanism of angina pectoris and myocardial infarction, and the physiological and pathological relationship of its network pharmacology. These findings not only provide a solid foundation for the clinical application of Salvia miltiorrhiza but also demonstrate its potential in preventing and controlling cardiovascular diseases.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"75 ","pages":"Article 102445"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Integrative Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876382025000174","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Angina pectoris and myocardial infarction, as the common causes and symptoms of cardiovascular disease, are one of the important research fields of traditional and complementary medicine. Using bibliometric methods, this study conducted a multidimensional analysis of the research trajectory of Salvia miltiorrhiza in the treatment of angina pectoris and myocardial infarction from 2007 to 2024, with a focus on its research characteristics, hot spots and frontiers.

Methods

Title, topic, abstract and author keywords related to Salvia miltiorrhiza, myocardial infarction and angina pectoris were utilized in the Web of Science Core Collection database to maximize the search related to the research topic. Co-authorship, co-occurrence and co-citation analysis of publications, countries, institutions, journals, authors, references and keywords were conducted using Citespace 6.3.R1, SCImago Graphica Beta 1.0.42, VOSviewer, Bibliometrix R Package and Microsoft Excel.

Results

The annual publication volume of studies related to the treatment of angina pectoris and myocardial infarction using Salvia miltiorrhiza exhibits phased changes, demonstrating a general upward trend. China is the country with the highest number of publications and citations, and it has established collaborations with multiple countries. Canada and India have emerged as significant participants in recent years. The number of authors and publications meets the requirements of Price's Law and the core author in this research field is Li, Xiang. The top three keywords are Salvia miltiorrhiza (75 occurrences), myocardial infarction (70 occurrences) and Danshen(37 occurrences).

Conclusions

The current hotspots of Salvia miltiorrhiza in the treatment of angina pectoris and myocardial infarction mainly focus on three aspects: the pharmacological effects of this herb and its active ingredients, the treatment mechanism of angina pectoris and myocardial infarction, and the physiological and pathological relationship of its network pharmacology. These findings not only provide a solid foundation for the clinical application of Salvia miltiorrhiza but also demonstrate its potential in preventing and controlling cardiovascular diseases.

查看原文本刊更多论文

丹参治疗心绞痛和心肌梗死：文献计量学分析

心绞痛和心肌梗死作为心血管疾病的常见病因和症状，是传统医学和补充医学的重要研究领域之一。本研究采用文献计量学方法，对2007 - 2024年丹参治疗心绞痛、心肌梗死的研究轨迹进行多维度分析，重点分析丹参的研究特点、热点和前沿。方法在Web of Science Core Collection数据库中利用丹参、心肌梗死、心绞痛相关的标题、主题、摘要和作者关键词，最大限度地进行与研究课题相关的检索。利用Citespace 6.3对出版物、国家、机构、期刊、作者、参考文献和关键词进行合著、共现和共被引分析。R1, SCImago Graphica Beta 1.0.42, VOSviewer， Bibliometrix R Package和Microsoft Excel。结果丹参治疗心绞痛、心肌梗死相关研究的年发表量呈现阶段性变化，总体呈上升趋势。中国是世界上发表论文和被引用次数最多的国家，并与多个国家建立了合作关系。近年来，加拿大和印度已成为重要的参与者。作者数量和出版物数量符合Price’s Law的要求，本研究领域的核心作者为李翔。排名前三的关键词分别是丹参（75次）、心肌梗死（70次）和丹参（37次）。结论目前丹参治疗心绞痛、心肌梗死的研究热点主要集中在中药及其有效成分的药理作用、心绞痛、心肌梗死的治疗机制及其网络药理学的生理病理关系三个方面。这些发现不仅为丹参的临床应用提供了坚实的基础，而且显示了丹参在预防和控制心血管疾病方面的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-

CiteScore

4.70

自引率

4.00%

发文量

102

审稿时长

33 days

期刊介绍： The European Journal of Integrative Medicine (EuJIM) considers manuscripts from a wide range of complementary and integrative health care disciplines, with a particular focus on whole systems approaches, public health, self management and traditional medical systems. The journal strives to connect conventional medicine and evidence based complementary medicine. We encourage submissions reporting research with relevance for integrative clinical practice and interprofessional education. EuJIM aims to be of interest to both conventional and integrative audiences, including healthcare practitioners, researchers, health care organisations, educationalists, and all those who seek objective and critical information on integrative medicine. To achieve this aim EuJIM provides an innovative international and interdisciplinary platform linking researchers and clinicians. The journal focuses primarily on original research articles including systematic reviews, randomized controlled trials, other clinical studies, qualitative, observational and epidemiological studies. In addition we welcome short reviews, opinion articles and contributions relating to health services and policy, health economics and psychology.